Proven to offer cost-effective solutions, Real-Time Location Systems (RTLS) can ease operational burdens for efficiency and enhance the relationship between patients and caregivers, enabling a more human-focused experience for all.
Even just a year ago, we couldn’t fathom a cure for cancer. Now, we can. Artificial intelligence (AI) is rapidly transforming the healthcare industry, with its ability to process and analyze vast amounts of data. Cancer treatment is one area that could benefit significantly from AI, as it can aid in early detection, precise diagnosis, and personalized treatment plans. With the rise of AI technologies, we could see significant advancements in cancer treatment, making it more efficient and potentially leading to a cure. Below, we’ll explore where we see the greatest opportunity for AI to make a meaningful impact on the fight against cancer along with important challenges and limitations to keep in mind. The great promise Early detection: Detection is naturally key in the treatment of cancer and AI can assist in identifying the disease at its earliest stages. By catching the disease early, patients have a higher chance of receiving successful treatment, and the cost of treatment can
A preview of ViVE 2024 offers a sneak peek at the agenda and how the Payer and Provider Connect meeting platform initiatives have been revamped to maximize the quantity and quality of meeting for healthcare executives.
Regeneron Pharmaceuticals is paying $5 million up front for 2seventy bio’s cancer drug pipeline. 2seventy will now focus on a cell therapy commercialized with partner Bristol Myers Squibb while Regeneron adds assets for its newly formed cell therapy division.
Chronic pain, an enduring concern for many older adults, is no longer confined to the traditional realm of pharmaceuticals. While traditional pain management methods like medication were once the go-to approach, alternative therapies are emerging as a viable and holistic approach to addressing this issue.